Nigeria’s well being authorities have cautioned that the newly launched long-acting HIV prevention injection, Lenacapavir (LenPrEP), shouldn’t be utilized by pregnant girls. The Director-Common of the Nationwide Company for the Management of AIDS, Dr. Temitope Ilori, defined this throughout a media briefing organised by the Nationwide HIV, Viral Hepatitis and STDs Management Programme in Abuja.

Though worldwide research point out that the drug is mostly protected, specialists say there may be not sufficient proof about the way it could have an effect on being pregnant, which is why its use in pregnant girls is at the moment restricted. Officers additionally emphasised that Lenacapavir is designed to forestall HIV an infection, to not deal with individuals who have already got the virus.

Well being authorities described the injection as a significant innovation in HIV prevention as a result of it solely must be administered twice a 12 months, making it simpler for individuals who battle to take every day capsules. Nonetheless, they burdened that it doesn’t defend towards different sexually transmitted infections or ailments resembling hepatitis, which means people should nonetheless practise complete sexual well being precautions.

The Nationwide Coordinator of the AIDS and STDs Management Programme, Adebobola Bashorun, famous that the federal government plans to develop entry to the drug throughout extra states and weak populations, with further funding being explored to assist wider distribution.

Officers additional clarified that Lenacapavir will complement present prevention strategies quite than exchange them. Choices resembling oral pre-exposure prophylaxis (PrEP) will stay obtainable, and nationwide tips will decide how the brand new injection suits into present programmes. Reported unintended effects to date have been delicate, primarily restricted to momentary ache on the injection website, with ongoing monitoring to make sure security as rollout continues.

The Minister of State for Well being, Dr. Iziaq Salako, said that Nigeria is introducing the drug with assist from the International Fund and hopes to finally interact producers straight, together with exploring prospects for native manufacturing. Discussions round know-how switch and home manufacturing are seen as key to long-term sustainability and decreasing dependence on overseas donors.

Lenacapavir, developed by Gilead Sciences, has drawn world consideration as a possible breakthrough due to its long-acting safety towards HIV. Nigeria carries one of many largest HIV burdens on the earth, with about 1.9 million individuals dwelling with the virus. Whereas remedy entry has improved considerably through the years, prevention gaps nonetheless exist, notably amongst younger individuals and high-risk teams.

Public well being specialists imagine the brand new injection may considerably strengthen Nigeria’s HIV prevention technique if it turns into broadly accessible. Nonetheless, issues stay about affordability, long-term funding, and whether or not the healthcare system can assist large-scale distribution with out neglecting different crucial well being priorities resembling malaria management, maternal care, and routine immunisation. For now, authorities view Lenacapavir as an vital addition to present prevention instruments, however not a single resolution to the nation’s HIV problem.

Lenacapavir itself is a long-acting antiviral drug designed to cease HIV from establishing an infection within the physique. It really works by interfering with the virus’s capacity to copy and unfold, providing prolonged safety from a single injection that lasts for months.

Not like conventional every day prevention capsules, this injection gives sustained drug ranges within the bloodstream, making it particularly helpful for individuals who could have issue sticking to a every day remedy routine. Nonetheless, as a result of it’s preventive quite than healing, it doesn’t eradicate HIV in people who find themselves already contaminated and have to be used alongside different protecting measures for full sexual well being security.